Skip to main content
Log in

The impact of supraphysiologic serum estradiol levels on peri-implantation embryo development and early pregnancy outcome following in vitro fertilization cycles

  • Assisted Reproduction Technologies
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

To determine the impact of elevated serum estradiol levels (EE2-defined as levels > 90th percentile) on the day of hCG administration during IVF on oocyte fertilization, embryo development, implantation, clinical pregnancy and miscarriage rates.

Methods

A total of 2,995 consecutive IVF cycles in 1,889 patients with non-donor oocyte retrieval resulting in fresh embryo transfer between 1/1/2005 and 12/31/2011 were analyzed. Cycles were stratified by serum E2 level on the day of hCG administration into those with levels >90th percentile and ≤ 90th percentile. Rates of normal fertilization, embryo development, positive pregnancy test, implantation, clinical pregnancy and spontaneous miscarriage were compared.

Results

Serum estradiol above the 90th percentile on the day of hCG administration was associated with a significantly lower rate of normal fertilization (68.6 ± 20 vs. 71.6 ± 21, p = 0.02) when compared with patients with a lower serum estradiol threshold. The proportion of embryos that progressed from 2PN to 6–8 cell on day 3 was not different between the two groups. Although rates of positive pregnancy test (55.2 % vs. 57 %), implantation (26.4 % vs. 28.5 %) and clinical pregnancy (45.5 % vs. 49.4 %) were lower in patients with a higher estradiol threshold, these differences were not statistically significant. Similarly, there was no difference in the spontaneous miscarriage rates between the two groups (8.4 % vs. 7.1 %).

Conclusions

Serum estradiol levels above the 90th percentile on the day of hCG administration is associated with lower oocyte fertilization rate; however, such levels do not impact embryo development, implantation, clinical pregnancy or spontaneous miscarriage rates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Allen VM, Wilson RD, Cheung A. Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can. 2006;28:220–50.

    PubMed  Google Scholar 

  2. Bohlmann MK, Fritzsching B, Luedders DW, Hornemann A, Gopel W, Poschl J, et al. Impact of assisted reproduction on obstetrics and neonatology. Z Geburtshilfe Neonatol. 2009;213:221–7.

    Article  CAS  PubMed  Google Scholar 

  3. Davies MJ, Moore VM, Willson KJ, Van Essen P, Priest K, Scott H, et al. Reproductive technologies and the risk of birth defects. New Engl J Med. 2012;366:1803–13.

    Article  CAS  PubMed  Google Scholar 

  4. Gelbaya TA. Short and long-term risks to women who conceive through in vitro fertilization. Hum Fertil (Camb). 2010;13:19–27.

    Article  Google Scholar 

  5. Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol. 2004;103:551–63.

    Article  PubMed  Google Scholar 

  6. McDonald SD, Han Z, Mulla S, Murphy KE, Beyene J, Ohlsson A. Preterm birth and low birth weight among in vitro fertilization singletons: a systematic review and meta-analyses. Eur J Obstet Gynecol Reprod Biol. 2009;146:138–48.

    Article  PubMed  Google Scholar 

  7. Perri T, Chen R, Yoeli R, Merlob P, Orvieto R, Shalev Y, et al. Are singleton assisted reproductive technology pregnancies at risk of prematurity? J Assist Reprod Genet. 2001;18:245–9.

    Article  CAS  PubMed  Google Scholar 

  8. Retzloff MG, Hornstein MD. Is intracytoplasmic sperm injection safe? Fertil Steril. 2003;80:851–9.

    Article  PubMed  Google Scholar 

  9. Schieve LA, Meikle SF, Ferre C, Peterson HB, Jeng G, Wilcox LS. Low and very low birth weight in infants conceived with use of assisted reproductive technology. New Engl J Med. 2002;346:731–7.

    Article  PubMed  Google Scholar 

  10. Tan SL, Doyle P, Campbell S, Beral V, Rizk B, Brinsden P, et al. Obstetric outcome of in vitro fertilization pregnancies compared with normally conceived pregnancies. Am J Obstet Gynecol. 1992;167:778–84.

    Article  CAS  PubMed  Google Scholar 

  11. Calhoun KC, Barnhart KT, Elovitz MA, Srinivas SK. Evaluating the association between assisted conception and the severity of preeclampsia. ISRN Obstet Gynecol. 2011;2011:928592.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Farhi J, Ben-Haroush A, Andrawus N, Pinkas H, Sapir O, Fisch B, et al. High serum oestradiol concentrations in IVF cycles increase the risk of pregnancy complications related to abnormal placentation. Reprod Biomed Online. 2010;21:331–7.

    Article  CAS  PubMed  Google Scholar 

  13. Imudia AN, Awonuga AO, Doyle JO, Kaimal AJ, Wright DL, Toth TL, et al. Peak serum estradiol level during controlled ovarian hyperstimulation is associated with increased risk of small for gestational age and preeclampsia in singleton pregnancies after in vitro fertilization. Fertil Steril. 2012;97:1374–9.

    Article  CAS  PubMed  Google Scholar 

  14. Barker DJ. In utero programming of chronic disease. Clin Sci (Lond). 1998;95:115–28.

    Article  CAS  Google Scholar 

  15. Chen QJ, Sun XX, Li L, Gao XH, Wu Y, Gemzell-Danielsson K, et al. Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH). Acta Obstet Gynecol Scand. 2007;86:849–54.

    Article  CAS  PubMed  Google Scholar 

  16. Forman R, Fries N, Testart J, Belaisch-Allart J, Hazout A, Frydman R. Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation. Fertil Steril. 1988;49:118–22.

    CAS  PubMed  Google Scholar 

  17. O’Neill C, Ferrier AJ, Vaughan J, Sinosich MJ, Saunders DM. Causes of implantation failure after in-vitro fertilisation and embryo transfer. Lancet. 1985;2:615.

    Article  PubMed  Google Scholar 

  18. Pellicer A, Valbuena D, Cano F, Remohi J, Simon C. Lower implantation rates in high responders: evidence for an altered endocrine milieu during the preimplantation period. Fertil Steril. 1996;65:1190–5.

    CAS  PubMed  Google Scholar 

  19. Chen QJ, Sun XX, Li L, Gao XH, Gemzell-Danielsson K, Cheng LN. Effects of ovarian stimulation on endometrial integrin beta3 and leukemia inhibitory factor expression in the peri-implantation phase. Fertil Steril. 2008;89:1357–63.

    Article  CAS  PubMed  Google Scholar 

  20. Gelety TJ, Buyalos RP. The influence of supraphysiologic estradiol levels on human nidation. J Assist Reprod Genet. 1995;12:406–12.

    Article  CAS  PubMed  Google Scholar 

  21. Gratton RJ, Nisker JA, Daniel S, Toth S, Gunter J, Kaplan BR, et al. An aggressive philosophy in controlled ovarian stimulation cycles increases pregnancy rates. Hum Reprod. 1993;8:528–31.

    CAS  PubMed  Google Scholar 

  22. Levi AJ, Drews MR, Bergh PA, Miller BT, Scott Jr RT. Controlled ovarian hyperstimulation does not adversely affect endometrial receptivity in in vitro fertilization cycles. Fertil Steril. 2001;76:670–4.

    Article  CAS  PubMed  Google Scholar 

  23. Simon C, Cano F, Valbuena D, Remohi J, Pellicer A. Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum Reprod. 1995;10:2432–7.

    Article  CAS  PubMed  Google Scholar 

  24. Sharara FI, McClamrock HD. High estradiol levels and high oocyte yield are not detrimental to in vitro fertilization outcome. Fertil Steril. 1999;72:401–5.

    Article  CAS  PubMed  Google Scholar 

  25. Tarin JJ, Sampaio MC, Calatayud C, Castellvi RM, Bonilla-Musoles F, Pellicer A. Relativity of the concept ‘high responder to gonadotrophins’. Hum Reprod. 1992;7:19–22.

    Article  CAS  PubMed  Google Scholar 

  26. Ehrlich S, Williams PL, Missmer SA, Flaws JA, Ye X, Calafat AM, et al. Urinary bisphenol A concentrations and early reproductive health outcomes among women undergoing IVF. Hum Reprod. 2012;27:3583–92.

    Article  CAS  PubMed  Google Scholar 

  27. Styer AK, Wright DL, Wolkovich AM, Veiga C, Toth TL. Single-blastocyst transfer decreases twin gestation without affecting pregnancy outcome. Fertil Steril. 2008;89:1702–8.

    Article  PubMed  Google Scholar 

  28. Pellicer A, Ruiz A, Castellvi RM, Calatayud C, Ruiz M, Tarin JJ, et al. Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophin-releasing hormone analogues (GnRHa) and gonadotrophins? Hum Reprod. 1989;4:536–40.

    CAS  PubMed  Google Scholar 

  29. Tarin JJ, Pellicer A. Consequences of high ovarian response to gonadotropins: a cytogenetic analysis of unfertilized human oocytes. Fertil Steril. 1990;54:665–70.

    CAS  PubMed  Google Scholar 

  30. Testart J, Belaisch-Allart J, Forman R, Gazengel A, Strubb N, Hazout A, et al. Influence of different stimulation treatments on oocyte characteristics and in-vitro fertilizing ability. Hum Reprod. 1989;4:192–7.

    CAS  PubMed  Google Scholar 

  31. Testart J, Forman R, Belaisch-Allart J, Volante M, Hazout A, Strubb N, et al. Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotrophin-releasing hormone. Hum Reprod. 1989;4:198–201.

    CAS  PubMed  Google Scholar 

  32. Harrod SB, Lacy RT, Morgan AJ. Offspring of prenatal IV nicotine exposure exhibit increased sensitivity to the reinforcing effects of methamphetamine. Front Pharmacol. 2012;3:116.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Lee DH, Steffes MW, Sjodin A, Jones RS, Needham LL, et al. Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes. PLoS One. 2011;6:e15997.

    Article  Google Scholar 

  34. Turer AT, Mahaffey KW, Honeycutt E, Tuttle RH, Shaw LK, et al. Influence of body mass index on the efficacy of revascularization in patients with coronary artery disease. J Thorac Cardiovasc Surg. 2009;137:1468–74.

    Article  PubMed  Google Scholar 

  35. Chenette PE, Sauer MV, Paulson RJ. Very high serum estradiol levels are not detrimental to clinical outcome of in vitro fertilization. Fertil Steril. 1990;54:858–63.

    CAS  PubMed  Google Scholar 

  36. Chen CH, Zhang X, Barnes R, Confino E, Milad M, Puscheck E, et al. Relationship between peak serum estradiol levels and treatment outcome in in vitro fertilization cycles after embryo transfer on day 3 or day 5. Fertil Steril. 2003;80:75–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anthony N. Imudia.

Additional information

Capsule Elevated estradiol levels on the day of hCG trigger is associated with lower oocyte fertilization during IVF

Rights and permissions

Reprints and permissions

About this article

Cite this article

Imudia, A.N., Goldman, R.H., Awonuga, A.O. et al. The impact of supraphysiologic serum estradiol levels on peri-implantation embryo development and early pregnancy outcome following in vitro fertilization cycles. J Assist Reprod Genet 31, 65–71 (2014). https://doi.org/10.1007/s10815-013-0117-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-013-0117-8

Keywords

Navigation